Neuroleptic malignant syndrome

Common Name(s)

Neuroleptic malignant syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroleptic malignant syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Neuroleptic malignant syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Neuroleptic malignant syndrome" returned 145 free, full-text research articles on human participants. First 3 results:

Neuroleptic malignant syndrome in cycloserine-induced psychosis.
 

Author(s): Neena S Sawant, Natasha S Kate, Swaroop S Bhatankar, Prathamesh S Kulkarni

Journal: Indian J Pharmacol. ;47(3):328-9.

 

A 33-year-old multidrug-resistant tuberculosis female patient diagnosed as cycloserine-induced psychosis developed several neuroleptic side effects such as extrapyramidal reaction, neuroleptic malignant syndrome, and drug-induced parkinsonism while she was being treated with initially ...

Last Updated: 13 Jun 2015

Go To URL
Neuroleptic malignant syndrome associated with metoclopramide in a child.
 

Author(s): Ayhan Yaman, Tanıl Kendirli, Çağlar Ödek, Caner Yıldız, Fırat Beğde, Hatice Erkol, Erdal İnce

Journal: Turk. J. Pediatr.. ;56(5):535-7.

 

Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal complication of treatment with antipsychotic medication. NMS has also been associated with non-neuroleptic agents that block central dopamine pathways, such as metoclopramide, amoxapine and lithium. Metoclopromide ...

Last Updated: 29 May 2015

Go To URL
Dopamine transporter single-photon emission computerized tomography supports diagnosis of akinetic crisis of parkinsonism and of neuroleptic malignant syndrome.
 

Author(s): G Martino, M Capasso, M Nasuti, L Bonanni, M Onofrj, A Thomas

Journal: Medicine (Baltimore). 2015 Apr;94(13):e649.

 

Akinetic crisis (AC) is akin to neuroleptic malignant syndrome (NMS) and is the most severe and possibly lethal complication of parkinsonism. Diagnosis is today based only on clinical assessments yet is often marred by concomitant precipitating factors. Our purpose is to evidence ...

Last Updated: 3 Apr 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Neuroleptic malignant syndrome" returned 23 free, full-text review articles on human participants. First 3 results:

A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review.
 

Author(s): Yu-Jie Chiou, Yu Lee, Chin-Chuen Lin, Tiao-Lai Huang

Journal: Medicine (Baltimore). 2015 Oct;94(43):e1752.

 

We describe a case with complicated clinical presentations who was difficult to treat. We described the possible etiologies and differential diagnosis of neuroleptic malignant syndrome (NMS), catatonia, and infection, in details. This patient was also referred to neuro-intensive care ...

Last Updated: 30 Oct 2015

Go To URL
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.
 

Author(s): Lurdes Tse, Alasdair M Barr, Vanessa Scarapicchia, Fidel Vila-Rodriguez

Journal: Curr Neuropharmacol. 2015 ;13(3):395-406.

 

Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening side-effect that can occur in response to treatment with antipsychotic drugs. Symptoms commonly include hyperpyrexia, muscle rigidity, autonomic dysfunction and altered mental status. In the current review ...

Last Updated: 28 Sep 2015

Go To URL
Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.
 

Author(s): Martino Belvederi Murri, Argentina Guaglianone, Michele Bugliani, Pietro Calcagno, Matteo Respino, Gianluca Serafini, Marco Innamorati, Maurizio Pompili, Mario Amore

Journal: Drugs R D. 2015 Mar;15(1):45-62.

 

Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally assumed to be free from the risk of causing NMS, however several cases of NMS induced by SGAs (SGA-NMS) have been reported.

Last Updated: 16 Mar 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
 

Status: Recruiting

Condition Summary: Rhabdomyolysis; Myopathy; Acute Renal Failure; Neuroleptic Malignant Syndrome

 

Last Updated: 30 Nov 2009

Go to URL
Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
 

Status: Recruiting

Condition Summary: Chronic Fatigue Syndrome; Myalgic Encephalomyelitis; Systemic Exertion Intolerance Disease (SEID); Postural Tachycardia Syndrome (POTS); Neurally Mediated Syncope (NMS)

 

Last Updated: 29 Jul 2016

Go to URL